Target intelligence / Profile preview

Transmembrane protein 222 (TMEM222)

Target
TMEM222
Molecular classification
Transmembrane protein, Domain of unknown function (DUF778)
01

Overview

Transmembrane protein 222 (TMEM222) is a human protein encoded by the TMEM222 gene, also known as C1orf160, located on chromosome 1p36.11[1][3][4]. The protein contains 208 amino acids and features three predicted transmembrane domains as well as a domain of unknown function (DUF778)[1][3]. TMEM222 is highly conserved across various eukaryotic organisms and is widely expressed in human tissues, with highest levels in the brain and in mature glutamatergic neurons, suggesting a specific function in neuronal development or synaptic activity[1][3]. Disease relevance has recently emerged, as biallelic deleterious variants in TMEM222 have been shown to cause an autosomal recessive neurodevelopmental disorder characterized by intellectual disability, motor and speech delay, and variable behavioral and neurological phenotypes, but the precise molecular function is not yet elucidated[3][4]. There is currently no evidence that TMEM222 is a therapeutic target, biomarker, or directly interacts with drugs[3][4].

Other names
TMEM222C1orf160DKFZP564D0478RP11-4K3__A.4MGC111002NEDMOSBAtransmembrane protein 222
02

Biological functions

Unknown (suggested roles in neuronal cell vesicles and potentially in postsynaptic vesicle function inferred from expression and localization studies)
03

Disease associations

Neurodevelopmental disorder with motor and speech delay (autosomal recessive intellectual disability with variable associated phenotypes)

Beyond the preview

Go deeper on Transmembrane protein 222 (TMEM222).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 222 (TMEM222).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call